KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

Soleus Capital Management, L.P.'s Holding History (CIK: 0001802630)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 224,600 Value ($000) $13,043 Avg Close $49.39 Range $40.93 - $59.06

Q2 2024

Shares 221,600 Value ($000) $10,127 Avg Close $53.73 Range $43.30 - $67.30

Q1 2024

Shares 273,600 Value ($000) $18,112 Avg Close $59.30 Range $39.00 - $73.00

Q3 2023

Shares 12,700 Value ($000) $405 Avg Close $37.33 Range $31.17 - $44.95

Q2 2023

Shares 70,800 Value ($000) $2,845 Avg Close $43.84 Range $37.03 - $51.16

Q1 2023

Shares 122,316 Value ($000) $5,223 Avg Close $50.51 Range $39.98 - $59.96

Q4 2022

Shares 233,116 Value ($000) $11,194 Avg Close $46.71 Range $37.40 - $52.78

Q3 2022

Shares 146,000 Value ($000) $5,493 Avg Close $34.66 Range $26.34 - $42.15

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	224,600	$13,043	$49.39	$40.93 - $59.06
Q2 2024	221,600	$10,127	$53.73	$43.30 - $67.30
Q1 2024	273,600	$18,112	$59.30	$39.00 - $73.00
Q3 2023	12,700	$405	$37.33	$31.17 - $44.95
Q2 2023	70,800	$2,845	$43.84	$37.03 - $51.16
Q1 2023	122,316	$5,223	$50.51	$39.98 - $59.96
Q4 2022	233,116	$11,194	$46.71	$37.40 - $52.78
Q3 2022	146,000	$5,493	$34.66	$26.34 - $42.15